4.7 Editorial Material

ASO Author Reflections: Which is the Optimal Preoperative Systemic Chemotherapy Regimen for Patients with Peritoneal Metastases from Colorectal Cancer?

Related references

Note: Only part of the references are listed.
Article Oncology

Comparison of Neoadjuvant Systemic Chemotherapy Protocols for the Curative-Intent Management of Peritoneal Metastases from Colorectal Cancer, Regarding Morphological Response, Pathological Response, and Long-Term Outcomes: A Retrospective Study

Florian Fanget et al.

Summary: In this retrospective study, a FOLFIRINOX regimen as NACT seemed to result in better long-term outcomes for CRPM patients after complete CRS/HIPEC, although with higher morbidity.

ANNALS OF SURGICAL ONCOLOGY (2023)

Article Surgery

Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases A Phase 2 Randomized Clinical Trial

Koen P. Rovers et al.

Summary: This phase 2 trial aimed to assess the feasibility, safety, and response of perioperative systemic therapy in patients with resectable colorectal peritoneal metastases (CPM), indicating the need for a phase 3 trial.

JAMA SURGERY (2021)